Therapeutic effect of oral Xuefu Zhuyu Pill combined with intravitreal injection of Aflibercept in the treatment of retinal vein occlusion
10.3980/j.issn.1672-5123.2025.9.26
- VernacularTitle:口服血府逐瘀丸联合玻璃体腔注射阿柏西普治疗视网膜静脉阻塞的疗效
- Author:
Ran SHEN
1
;
Hongying JI
1
;
Hongyu CUI
1
;
Lequan YANG
1
;
Lixia GUO
1
Author Information
1. Department of Ophthalmology, Handan City Eye Hospital(The Third Hospital of Handan), Handan 056001, Hebei Province, China
- Publication Type:Journal Article
- Keywords:
Xuefu Zhuyu Pill;
Aflibercept;
retinal vein occlusion;
retinal microcirculation;
macular edema
- From:
International Eye Science
2025;25(9):1532-1536
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To explore the therapeutic effect of oral Xuefu Zhuyu Pill combined with intravitreal injection of aflibercept in the treatment of retinal vein occlusion(RVO).METHODS: A total of 80 patients(80 eyes)with RVO admitted to our hospital from January 2021 to March 2024 were prospectively selected. According to the treatment method, they were divided into a control group of 40 patients treated with intravitreal injection of aflibercept, and an observation group of 40 patients treated with oral Xuefu Zhuyu Pill combined with intravitreal injection of aflibercept. The efficacy, TCM syndrome score, retinal microcirculation parameters, macular edema(ME), and adverse reactions were compared between the two groups of patients in the treatment of RVO.RESULTS: All patients have completed follow-up. The clinical effective rate of the observation group after treatment was 95%, obviously higher than that of the control group(80%; χ2=4.114, P=0.043). After treatment for 3 mo, the traditional Chinese medicine syndrome scores, foveal avascular area(FAZ)area, FAZ circumference, macular central retinal thickness, and neovascularization leakage area of both groups decreased, the overall blood flow density of the superficial capillary plexus(SCP)and deep capillary plexuses(DCP)increased, and the observation group showed better results than the control group(all P<0.05). There was no statistically significant difference in the occurrence of adverse reactions between the two groups during the treatment period(P>0.05).CONCLUSION: Oral administration of Xuefu Zhuyu Pill combined with intravitreal injection of aflibercept in the treatment of RVO can improve retinal microcirculation, enhance vision, restore ocular blood circulation, improve bleeding, promote ME absorption, and improve clinical efficacy.
